Publication | Closed Access

Combined treatment of colorectal tumours with agonistic TRAIL receptor antibodies HGS-ETR1 and HGS-ETR2 and radiotherapy: enhanced effects in vitro and dose-dependent growth delay in vivo

MedicineImmunologyCancer GrowthColorectal CancerPathologyImmune Checkpoint InhibitorEnhanced EffectsCancer TreatmentDose-dependent Growth DelayOncologyRadiation OncologyTumor MicroenvironmentColorectal Tumours